Perfusion Blog Posts
CABG Shows Survival Advantage Over PCI in Nondiabetic Patients With Multivessel Disease
The theory that contemporary PCI might diminish the advantage of CABG in patients with multivessel disease does not appear to be valid, at least based on pooled patient-level data from two large randomized trials. “CABG, as compared with PCI with DES, significantly reduced the long-term risk of mortality in nondiabetic patients with multivessel CAD,” write […]
Perfusion Blog Posts
HIPEC Provides New Hope for Cancer Patients
For certain late stage cancer patients a specialized procedure called hyperthermic intraperitoneal chemotherapy (HIPEC) can provide a “new lease on life,” as a specialized treatment method. Wilbur B. Bowne, MD, an associate professor at the Drexel University College of Medicine and the chief of gastrointestinal surgery at Hahnemann University Hospital discussed how HIPEC has […]
Perfusion Blog Posts
Prematurely born lambs kept alive in artificial external placenta – human babies could be next
When babies are born extremely prematurely – before 24 weeks of development in the womb – their lungs aren’t strong enough to provide their organs with the oxygen needed to develop properly. Nor are they strong enough to handle artificial ventilation. The result can mean a brief life for these tiniest of babies. A new artificial placenta that mimics conditions in the womb being developed by researchers at the University of Michigan (UM) might provide new hope. […]
Perfusion Blog Posts
The most unexpected hospital billing development ever: Refunds
DANVILLE, Pa. — At Geisinger Health System in Pennsylvania, hospital officials want to keep their customers happy. So when patients are upset about a long wait in the emergency department, or a doctor’s brusque manner, or a meal that never arrived in a room, Geisinger is doing more than apologizing. It’s offering money back on […]
Perfusion Blog Posts
CABG reduces 10-year mortality rate in patients with ischemic cardiomyopathy
CHICAGO — Compared with medical therapy alone, CABG plus medical therapy reduced mortality rates over 10 years in patients with ischemic cardiomyopathy, according to long-term results of the STICHES trial reported at the American College of Cardiology Scientific Session. Eric J. Velazquez, MD, and colleagues randomly assigned 1,212 patients with left ventricular ejection fraction 35% […]
Perfusion Blog Posts
LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery
LivaNova, PLC, a global medical technology company and a leader in the treatment of cardiovascular diseases, announced the first U.S. implantation of the Perceval valve, the sutureless biological aortic replacement valve. Performed last week, two valves were implanted by Douglas Johnston, M.D., and Eric Roselli, M.D., […]
Perfusion Blog Posts
University of Michigan Health System tests beating heart transplants
Despite advances in organ transplantation, the way donor hearts are moved from hospital to hospital remains low-tech: stored on ice and carried in a store-bought cooler. The University of Michigan Health System is testing a new high-tech heart box that […]
Perfusion Blog Posts
How Aortic Aneurysms Become Aortic Catastrophes
Patients with an acute illness to their aorta are unbelievably fragile, requiring tight control of their condition by educated and dedicated providers. This frailty coupled with the risk of instantaneous and irreversible cardiovascular collapse are what give aortic catastrophes such a reputation and need for such surveillance. […]
Perfusion Blog Posts
FDA likely to approve expanded indication of Abiomed's Impella heart pump: SEC filing
Abiomed ($ABMD) revealed in an SEC filing that the FDA has agreed to forgo an advisory panel meeting to discuss an expanded indication for its Impella 2.5, Impella CP, Impella 5.0 and Impella LD heart pumps, meaning permission to use the devices on emergency patients suffering from cardiogenic shock is a near certainty, and should […]
Perfusion Blog Posts
Researchers develop model of in-hospital mortality for patients undergoing TAVR
Researchers have developed a model of in-hospital mortality for patients undergoing transcatheter aortic valve replacement (TAVR) using data from the Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) registry. The model will be incorporated in the registry’s software and will help select patients who may benefit from TAVR. Lead researcher Fred H. […]
Recent Comments